Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer

被引：0
|
作者：
Seema Agarwal
Frank B Gertler
Michele Balsamo
John S Condeelis
Robert L Camp
Xiaonan Xue
Juan Lin
Thomas E Rohan
David L Rimm
机构：
[1] Yale University School of Medicine,Department of Pathology
[2] Massachusetts Institute of Technology,Department of Biology and Koch Institute for Integrative Cancer Research
[3] Albert Einstein College of Medicine,Department of Anatomy and Structural Biology, Gruss Lipper Biophotonics Center
[4] Albert Einstein College of Medicine,Department of Epidemiology and Population Health
来源：
Breast Cancer Research | / 14卷
关键词：
Breast Cancer; Benzoic Hydrazide; Index Array; Haven Hospital; Mouse Breast Cancer Model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
    Agarwal, Seema
    Gertler, Frank B.
    Balsamo, Michele
    Condeelis, John S.
    Camp, Robert L.
    Xue, Xiaonan
    Lin, Juan
    Rohan, Thomas E.
    Rimm, David L.
    BREAST CANCER RESEARCH, 2012, 14 (05):
  • [2] Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
    Catherine L. Forse
    Seema Agarwal
    Dushanthi Pinnaduwage
    Frank Gertler
    John S. Condeelis
    Juan Lin
    Xiaonan Xue
    Kimberly Johung
    Anna Marie Mulligan
    Thomas E. Rohan
    Shelley B. Bull
    Irene L. Andrulis
    BMC Cancer, 15
  • [3] Menacalc, a Quantitative Method of Metastasis Assessment, as a Prognostic Marker for Axillary Node-Negative Breast Cancer
    Forse, C. L.
    Agarwal, S.
    Pinnaduwage, D.
    Gertler, F.
    Condeelis, J.
    Lin, J.
    Xue, X.
    Rohan, T. E.
    Rumm, D. L.
    Andrulis, I. L.
    LABORATORY INVESTIGATION, 2014, 94 : 49A - 49A
  • [4] Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
    Forse, Catherine L.
    Agarwal, Seema
    Pinnaduwage, Dushanthi
    Gertler, Frank
    Condeelis, John S.
    Lin, Juan
    Xue, Xiaonan
    Johung, Kimberly
    Mulligan, Anna Marie
    Rohan, Thomas E.
    Bull, Shelley B.
    Andrulis, Irene L.
    BMC CANCER, 2015, 15
  • [5] Menacalc, a Quantitative Method of Metastasis Assessment, as a Prognostic Marker for Axillary Node-Negative Breast Cancer
    Forse, C. L.
    Agarwal, S.
    Pinnaduwage, D.
    Gertler, F.
    Condeelis, J.
    Lin, J.
    Xue, X.
    Rohan, T. E.
    Rimm, D. L.
    Andrulis, I. L.
    MODERN PATHOLOGY, 2014, 27 : 49A - 49A
  • [6] Quantitative assessment of miR34a as an independent prognostic marker in breast cancer
    Agarwal, Seema
    Hanna, J.
    Sherman, M. E.
    Figueroa, J.
    Rimm, D. L.
    BRITISH JOURNAL OF CANCER, 2015, 112 (01) : 61 - 68
  • [7] Quantitative assessment of miR34a as an independent prognostic marker in breast cancer
    Seema Agarwal
    J Hanna
    M E Sherman
    J Figueroa
    D L Rimm
    British Journal of Cancer, 2015, 112 : 61 - 68
  • [8] TMEM and Menacalc: New prognostic markers for breast cancer
    Rohan, Thomas E.
    Oktay, Maja H.
    Sparano, Joseph A.
    Jones, Joan G.
    Entenberg, David R.
    Condeelis, John S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 129 - 129
  • [9] RECK is not an independent prognostic marker for breast cancer
    Gomes, Luciana R.
    Fujita, Andre
    Mott, Joni D.
    Soares, Fernando A.
    Labriola, Leticia
    Sogayar, Mari C.
    BMC CANCER, 2015, 15
  • [10] RECK is not an independent prognostic marker for breast cancer
    Luciana R. Gomes
    André Fujita
    Joni D. Mott
    Fernando A. Soares
    Leticia Labriola
    Mari C. Sogayar
    BMC Cancer, 15
12345